An off-the-shelf solution with a single-stage procedure for knee cartilage and osteochondral defect repair,1 comprised of a proprietary implant biomaterial that is porous, biocompatible and biodegradable.2,3
Derived from a naturally occurring calcium carbonate known as aragonite, the CARTIHEAL AGILI-C Implant is a porous, biodegradable2,3 and biphasic biomaterial scaffold for cartilage regeneration.
Shown to deliver clinically meaningful improvements in pain, function and quality of life,1 the CARTIHEAL AGILI-C Implant is the only device approved for the treatment of knee cartilage and osteochondral defects in patients with or without mild to moderate osteoarthritis (KL 0-3).4
Effective: Twice the pain reduction*4
Versatile: Treat small and large lesions, with or without the presence of osteoarthritis(OA)1
Convenient: Implanted using a single, simple surgical procedure, with no need fordonor matching or cell harvesting
The MyKneeHealth Patient Access Program will facilitate your patient’s access to treatment through the submission of comprehensive requests for prior authorization and internal patient-based appeals, up to and including an external review.
By enrolling in the MyKneeHealth Patient Access Program providers receive assistance with benefit verification and appeals for denied authorizations and claims.
*Compared to the surgical standard (microfracture or debridement).
**Illustration only; not an actual representation.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.
To order the instruments used in this technique, call +1 800 343 5717 in the U.S. or contact an authorized Smith+Nephew representative. Prior to performing this technique, consult the Instructions for Use documentation provided with individual components – including indications, contraindications, warnings, cautions and instructions. Individual patient responses may vary.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
1.CartiHeal 2009. Indications for Use: Agili-C™ implant.
2. Kon E, et al. J Orthop Surg Res. 2015 May 28;10:81.
3. Kon E, et al. Knee Surg Sports Traumatol Arthrosc. 2014 Jun;22(6):1452-64.
4. Altschuler, et al. AJSM 2023: 51(4), 957-967.
5. Kon E, et al. Am J Sports Med. 2021 Mar;49(3):588-598
Text